Period 2 Regulates CYP2B10 Expression and Activity in Mouse Liver
CYP2B10 is responsible for metabolism and detoxification of many clinical drugs. Here, we aimed to investigate a potential role of Period 2 (PER2) in regulating expression of hepatic CYP2B10. Regulatory effects of PER2 on hepatic expression of CYP2B10 and other enzymes were determined using Per2-def...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-11-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.764124/full |
_version_ | 1818401907588202496 |
---|---|
author | MengLin Chen MengLin Chen Min Chen Min Chen Danyi Lu Yi Wang Yi Wang Li Zhang Li Zhang Zhigang Wang Baojian Wu |
author_facet | MengLin Chen MengLin Chen Min Chen Min Chen Danyi Lu Yi Wang Yi Wang Li Zhang Li Zhang Zhigang Wang Baojian Wu |
author_sort | MengLin Chen |
collection | DOAJ |
description | CYP2B10 is responsible for metabolism and detoxification of many clinical drugs. Here, we aimed to investigate a potential role of Period 2 (PER2) in regulating expression of hepatic CYP2B10. Regulatory effects of PER2 on hepatic expression of CYP2B10 and other enzymes were determined using Per2-deficient mice with exons 4-6 deleted (named Per2Del4-6 mice). In vitro and in vivo metabolic activities of CYP2B10 were probed using cyclophosphamide (CPA) as a specific substrate. Regulatory mechanism was investigated using luciferase reporter assays. Genotyping and Western blotting demonstrated loss of wild-type Per2 transcript and markedly reduced PER2 protein in Per2Del4-6 mice. Hepatic expression of a plenty of drug-metabolizing genes (including Cyp2a4/2a5, Cyp2b10, Ugt1a1, Ugt1a9, Ugt2b36, Sult1a1 and Sult1e1) were altered (and majority were down-regulated) in Per2Del4-6 mice. Of note, Cyp2b10, Ugt1a9 and Sult1a1 were three genes considerably affected with reduced expression. Decreased expression of CYP2B10 was translated to reduced metabolism and altered pharmacokinetics of CPA as well as attenuated CPA hepatotoxicity in Per2Del4-6 mice. Positive regulation of CYP2B10 by PER2 was further confirmed in both Hepa-1c1c7 and AML-12 cells. Based on luciferase reporter assays, it was shown that PER2 regulated Cyp2b10 transcription in a REV-ERBα-dependent manner. REV-ERBα was negatively regulated by PER2 (increased REV-ERBα expression in Per2Del4-6 mice) and itself was also a repressor of CYP2B10. In conclusion, PER2 positively regulates CYP2B10 expression and activity in mouse liver through inhibiting its repressor REV-ERBα. |
first_indexed | 2024-12-14T07:59:56Z |
format | Article |
id | doaj.art-014a37401264465bb354052a0ed7740f |
institution | Directory Open Access Journal |
issn | 1663-9812 |
language | English |
last_indexed | 2024-12-14T07:59:56Z |
publishDate | 2021-11-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Pharmacology |
spelling | doaj.art-014a37401264465bb354052a0ed7740f2022-12-21T23:10:27ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122021-11-011210.3389/fphar.2021.764124764124Period 2 Regulates CYP2B10 Expression and Activity in Mouse LiverMengLin Chen0MengLin Chen1Min Chen2Min Chen3Danyi Lu4Yi Wang5Yi Wang6Li Zhang7Li Zhang8Zhigang Wang9Baojian Wu10College of Pharmacy, Jinan University, Guangzhou, ChinaInstitute of Molecular Rhythm and Metabolism, Guangzhou University of Chinese Medicine, Guangzhou, ChinaCollege of Pharmacy, Jinan University, Guangzhou, ChinaInstitute of Molecular Rhythm and Metabolism, Guangzhou University of Chinese Medicine, Guangzhou, ChinaInstitute of Molecular Rhythm and Metabolism, Guangzhou University of Chinese Medicine, Guangzhou, ChinaCollege of Pharmacy, Jinan University, Guangzhou, ChinaInstitute of Molecular Rhythm and Metabolism, Guangzhou University of Chinese Medicine, Guangzhou, ChinaCollege of Pharmacy, Jinan University, Guangzhou, ChinaInstitute of Molecular Rhythm and Metabolism, Guangzhou University of Chinese Medicine, Guangzhou, ChinaDepartment of Intensive Care Unit, First Affiliated Hospital of Jinan University, Guangzhou, ChinaInstitute of Molecular Rhythm and Metabolism, Guangzhou University of Chinese Medicine, Guangzhou, ChinaCYP2B10 is responsible for metabolism and detoxification of many clinical drugs. Here, we aimed to investigate a potential role of Period 2 (PER2) in regulating expression of hepatic CYP2B10. Regulatory effects of PER2 on hepatic expression of CYP2B10 and other enzymes were determined using Per2-deficient mice with exons 4-6 deleted (named Per2Del4-6 mice). In vitro and in vivo metabolic activities of CYP2B10 were probed using cyclophosphamide (CPA) as a specific substrate. Regulatory mechanism was investigated using luciferase reporter assays. Genotyping and Western blotting demonstrated loss of wild-type Per2 transcript and markedly reduced PER2 protein in Per2Del4-6 mice. Hepatic expression of a plenty of drug-metabolizing genes (including Cyp2a4/2a5, Cyp2b10, Ugt1a1, Ugt1a9, Ugt2b36, Sult1a1 and Sult1e1) were altered (and majority were down-regulated) in Per2Del4-6 mice. Of note, Cyp2b10, Ugt1a9 and Sult1a1 were three genes considerably affected with reduced expression. Decreased expression of CYP2B10 was translated to reduced metabolism and altered pharmacokinetics of CPA as well as attenuated CPA hepatotoxicity in Per2Del4-6 mice. Positive regulation of CYP2B10 by PER2 was further confirmed in both Hepa-1c1c7 and AML-12 cells. Based on luciferase reporter assays, it was shown that PER2 regulated Cyp2b10 transcription in a REV-ERBα-dependent manner. REV-ERBα was negatively regulated by PER2 (increased REV-ERBα expression in Per2Del4-6 mice) and itself was also a repressor of CYP2B10. In conclusion, PER2 positively regulates CYP2B10 expression and activity in mouse liver through inhibiting its repressor REV-ERBα.https://www.frontiersin.org/articles/10.3389/fphar.2021.764124/fullPER2Cyp2b10REV-ERBαcyclophosphamidedrug metabolism |
spellingShingle | MengLin Chen MengLin Chen Min Chen Min Chen Danyi Lu Yi Wang Yi Wang Li Zhang Li Zhang Zhigang Wang Baojian Wu Period 2 Regulates CYP2B10 Expression and Activity in Mouse Liver Frontiers in Pharmacology PER2 Cyp2b10 REV-ERBα cyclophosphamide drug metabolism |
title | Period 2 Regulates CYP2B10 Expression and Activity in Mouse Liver |
title_full | Period 2 Regulates CYP2B10 Expression and Activity in Mouse Liver |
title_fullStr | Period 2 Regulates CYP2B10 Expression and Activity in Mouse Liver |
title_full_unstemmed | Period 2 Regulates CYP2B10 Expression and Activity in Mouse Liver |
title_short | Period 2 Regulates CYP2B10 Expression and Activity in Mouse Liver |
title_sort | period 2 regulates cyp2b10 expression and activity in mouse liver |
topic | PER2 Cyp2b10 REV-ERBα cyclophosphamide drug metabolism |
url | https://www.frontiersin.org/articles/10.3389/fphar.2021.764124/full |
work_keys_str_mv | AT menglinchen period2regulatescyp2b10expressionandactivityinmouseliver AT menglinchen period2regulatescyp2b10expressionandactivityinmouseliver AT minchen period2regulatescyp2b10expressionandactivityinmouseliver AT minchen period2regulatescyp2b10expressionandactivityinmouseliver AT danyilu period2regulatescyp2b10expressionandactivityinmouseliver AT yiwang period2regulatescyp2b10expressionandactivityinmouseliver AT yiwang period2regulatescyp2b10expressionandactivityinmouseliver AT lizhang period2regulatescyp2b10expressionandactivityinmouseliver AT lizhang period2regulatescyp2b10expressionandactivityinmouseliver AT zhigangwang period2regulatescyp2b10expressionandactivityinmouseliver AT baojianwu period2regulatescyp2b10expressionandactivityinmouseliver |